2019-nCOV situation: 9 Feb 2020
To view images in this newsletter, please allow images and html options.
Pandemic Threats and Health Emergencies
2019-nCOV situation: 9 Feb 2020
Welcome to this special issue of the newsletter where we highlight latest research and policy news and literature on 2019-nCVO situation
Please send your feedback, articles and reports, or questions you would like to share to Dr. Chadia Wannous via email email@example.com
Wishing you useful reading!
WHO situation report no 19 on 8 Feb
- No new countries reported cases of 2019-nCoV in the past 24 hours.
- The infection prevention and control (IPC) global network is convened through weekly teleconferences with international IPC experts to discuss technical aspects of IPC measures, share epidemiological updates and experiences regarding the IPC measures put in place in affected countries. In consultation with the global IPC expert network, WHO has released three key IPC interim guidance materials on IPC measures during health care and home care, as well as advice on the use of masks in various settings.
- WHO RISK ASSESSMENT
China Very High
Regional Level High
Global Level High
Novel coronavirus (2019-nCoV) situation as of 09 February 2020, 10:00 (CET)
China’s National Health Commission Feb 9: Daily briefing on novel coronavirus cases in China
On Feb 8, 31 provincial-level regions on the Chinese mainland as well as the Xinjiang Production and Construction Corps reported 2,656 new cases of confirmed infections (including 2,147 in Hubei province), 3,916 new cases of suspected infections (including 2,067 in Hubei province), 87 new serious cases (including 52 in Hubei province), and 89 deaths (81 in Hubei province, 2 in Henan province, 1 in Hebei province, 1 in Heilongjiang province, 1 in Anhui province, 1 in Shandong province, 1 in Hunan province, and 1 in Guangxi Zhuang autonomous region). 600 patients were released from hospitals after being cured, including 324 in Hubei province. 31,124 people who had had close contact with infected patients were freed from medical observation.
China Latest developments in epidemic control on Feb 8 (1)
BEIJING — China has stepped up efforts to curb the spread of the novel coronavirus (2019-nCoV). Here are the latest developments:
— Chinese health authorities said on Feb 8 that they received reports of 3,399 new confirmed cases of novel coronavirus infection and 86 deaths on Feb 7 from 31 provincial-level regions and the Xinjiang Production and Construction Corps.
— The overall confirmed cases on the Chinese mainland had reached 34,546 by the end of Feb 7 and 722 people had died of the disease.
— A total of 2,050 patients infected with the novel coronavirus had been discharged from hospital after recovery by the end of Feb 7, Chinese health authorities announced on Feb 8.
— Pangolins may be an intermediate host of the virus, as indicated by a study led by South China Agricultural University. Researchers found the metagenome sequence of the novel coronavirus strain separated from pangolins to be 99 percent identical to that from infected people.
— Wuhan, the epicenter of the novel coronavirus outbreak, is in a citywide mobilization to comb communities to ensure every confirmed or suspected patient is located and attended to as a senior official vowed to nail any official deserter "to history's pillar of shame."
— Beijing on Feb 7 published the number of patients suspected to be infected with the novel coronavirus for the first time.
Daily novel coronavirus pneumonia cases drop outside epicenter province
Countries with confirmed cases as of 9 Feb at 10.00 CET
China: 37251 Cases
Singapore: 40 Cases
Thailand: 32 Cases
Republic of Korea: 27 Cases
Japan: 26 Cases
Malaysia: 17 Cases
Australia: 15 Cases
Germany: 14 Cases
Viet Nam: 14 Cases
United States of America: 12 Cases
France: 11 Cases
Canada: 7 Cases
United Arab Emirates: 7 Cases
India: 3 Cases
Italy: 3 Cases
Philippines: 3 Cases
United Kingdom: 3 Cases
Russian Federation: 2 Cases
Cambodia: 1 Cases
Finland: 1 Cases
Nepal: 1 Cases
Sri Lanka: 1 Cases
Spain: 1 Cases
Sweden: 1 Cases
Belgium: 1 Cases
Consequences of the Outbreak on Economy
WIDER IMAGE-Coronavirus turns busy Chinese cities into ghost towns
Coronavirus: demand for face masks creates shortfall for those in real need
Unprecedented global demand for face masks and other protective equipment fuelled by the coronavirus epidemic, has created potentially dangerous shortages for those who need them most, the World Health Organization (WHO) announced on Friday.
Health officials worldwide urge calm amid rigorous Chinese battle against coronavirus
Experts warn quarantined cruise ships will stoke public fears over nCoV
Health officials navigate tough issues when deciding how to manage potential exposure on cruise ships.
WHO warns of PPE shortage
WHO officials said the problem doesn't relate to surgical masks worn by the public, but rather PPE materials used in medical care, such as N95 masks.
Mike Ryan, MD, who heads the WHO's health emergencies program, said there are many stakeholders across the PPE network, including raw-materials providers, manufacturers, wholesalers, distributors, and retailers. "This is not an easy problem to solve," he said, adding that the public and private sector need to cooperate closely so that health workers who need it aren't without PPE.
Online training as a weapon to fight the new coronavirus
China allocates $10.26 billion to fight coronavirus
Shanghai launches hospitality industrial guideline for epidemic control
New UK aid to help stop the spread of coronavirus around the world
UK aid will help prevent the spread of the virus in developing countries, by supporting them to rapidly identify and care for patients with symptoms.
The United States Announces Assistance To Combat the Novel Coronavirus
Today, the United States government is announcing it is prepared to spend up to $100 million in existing funds to assist China and other impacted countries, both directly and through multilateral organizations, to contain and combat the novel coronavirus.
Scientific publications and reports and news
Phylogenetic analysis of nCoV-2019 genomes
Most estimates since the first data was produced have produced a date that is consistent with the epidemiological reports of a first cluster of cases in December at a seafood market in Wuhan City. As more genomes have been generated, this is looking increasingly supported by the timing of the MRCA of the sampled genomes.
The genome sequence data shows no evidence that any non-human animal reservoir has been involved in generating new cases after the initial zoonotic event. If cases in January had been the result of new zoonotic jumps from a reservoir, we would expect those genomes to be more divergent and lie outside the observed diversity to that point.
We can conclude therefore, based on available genome sequence data that the current epidemic has been driven entirely by human to human transmission at least since December. Although this virus may still exist in one or more non-human animal species this will not be of major consequence until the current human epidemic is brought under control.
Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China
The virus has spread to different parts of China and at least 26 other countries.1 A high number of men have been infected, and the reported mortality rate has been approximately 2%, which is lower than that reported from other coronavirus epidemics including severe acute respiratory syndrome (SARS; mortality rate, >40% in patients aged >60 years)5 and Middle East respiratory syndrome (MERS; mortality rate, 30%).6 However, little is known about the clinical manifestations of 2019-nCoV in healthy populations or cases outside Wuhan. We report early clinical features of 13 patients with confirmed 2019-nCoV infection admitted to hospitals in Beijing.
The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance
Associations of Processed Meat, Unprocessed Red Meat, Poultry, or Fish Intake With Incident Cardiovascular Disease and All-Cause Mortality
N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial
In this pragmatic, cluster randomized clinical trial involving 2862 health care personnel, there was no significant difference in the incidence of laboratory-confirmed influenza among health care personnel with the use of N95 respirators (8.2%) vs medical masks (7.2%).
What Ebola Teaches Us About Controlling Coronavirus
CDC released interim guidance for businesses and employers
offering advice for preventing 2019-nCoV and other respiratory illnesses in nonmedical workplace settings. It also covers planning considerations if there are widespread community outbreaks of 2019-nCoV in the United States.
Fighting coronavirus fear with empathy: Lessons learned from how Africans got blamed for Ebola
Reporter's Notebook: Life and death in a Wuhan coronavirus ICU
A virtual press conference will be held at the World Health Organization in Geneva at 5:30 pm on Wednesday 12 February following the global research and innovation forum convened by WHO.
The forum is organized in collaboration with the Global Research Collaboration for Infectious Disease Preparedness. It will bring together key players including leading scientists as well as public health agencies, ministries of health and research funders pursuing 2019-nCoV critical animal health and public health research and the development of vaccines, therapeutics and diagnostics, among other innovations.
Media contacts: Tarik Jasarevic at firstname.lastname@example.org
or Christian Lindmeier at email@example.com
WHO Technical guidance
- Surveillance and case definitions
- Laboratory guidance
- Clinical management for suspected novel coronavirus
- Home care for patients with suspected novel coronavirus
- Infection prevention and control
- Risk communications
- Readiness checklist
- Disease commodity package
- Reducing transmission from animals to humans
- Early investigations
WHO Critical Care Severe Acute Respiratory Infection Training
This course is intended for clinicians who are working in intensive care units (ICUs) in low and middle-income countries and managing adult and pediatric patients with severe forms of acute respiratory infection (SARI), including severe pneumonia, acute respiratory distress syndrome (ARDS), sepsis and septic shock. It is a hands-on practical guide to be used by health care professionals involved in critical care management during outbreaks of influenza virus (seasonal) human infection due avian influenza virus (H5N1, H7N9), MERS-CoV, nCoV or other emerging respiratory viral epidemics.
Thank you for reading. If you have thoughts, feedback, story ideas, or questions you would like to share or interested in partnering with us on a special event coverage, please send a note to Chadia Wannous via email firstname.lastname@example.org